1. Home
  2. EXFY vs MOLN Comparison

EXFY vs MOLN Comparison

Compare EXFY & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXFY
  • MOLN
  • Stock Information
  • Founded
  • EXFY 2008
  • MOLN 2004
  • Country
  • EXFY United States
  • MOLN Switzerland
  • Employees
  • EXFY N/A
  • MOLN N/A
  • Industry
  • EXFY Computer Software: Prepackaged Software
  • MOLN
  • Sector
  • EXFY Technology
  • MOLN
  • Exchange
  • EXFY Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • EXFY 165.4M
  • MOLN 157.8M
  • IPO Year
  • EXFY 2021
  • MOLN 2021
  • Fundamental
  • Price
  • EXFY $1.53
  • MOLN $4.10
  • Analyst Decision
  • EXFY Strong Buy
  • MOLN Hold
  • Analyst Count
  • EXFY 3
  • MOLN 1
  • Target Price
  • EXFY $4.75
  • MOLN $4.00
  • AVG Volume (30 Days)
  • EXFY 502.1K
  • MOLN 10.9K
  • Earning Date
  • EXFY 11-06-2025
  • MOLN 10-30-2025
  • Dividend Yield
  • EXFY N/A
  • MOLN N/A
  • EPS Growth
  • EXFY N/A
  • MOLN N/A
  • EPS
  • EXFY N/A
  • MOLN N/A
  • Revenue
  • EXFY $143,907,000.00
  • MOLN N/A
  • Revenue This Year
  • EXFY $5.45
  • MOLN N/A
  • Revenue Next Year
  • EXFY $2.56
  • MOLN $1,000.00
  • P/E Ratio
  • EXFY N/A
  • MOLN N/A
  • Revenue Growth
  • EXFY 4.71
  • MOLN N/A
  • 52 Week Low
  • EXFY $1.33
  • MOLN $3.36
  • 52 Week High
  • EXFY $4.13
  • MOLN $5.99
  • Technical
  • Relative Strength Index (RSI)
  • EXFY 48.17
  • MOLN 51.69
  • Support Level
  • EXFY $1.42
  • MOLN $3.99
  • Resistance Level
  • EXFY $1.53
  • MOLN $4.11
  • Average True Range (ATR)
  • EXFY 0.09
  • MOLN 0.29
  • MACD
  • EXFY 0.02
  • MOLN -0.03
  • Stochastic Oscillator
  • EXFY 86.67
  • MOLN 26.14

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: